Paul Jones is a registered Trans-Tasman Patent Attorney and has practiced in the IP field for over 40 years. He has a Bachelor of Applied Science (Chemistry) degree from the University of Melbourne.
Throughout his career, Paul has specialised in the fields of pharmaceutical, agricultural, and veterinary chemistry, with a particular emphasis on strategic advice and IP exploitation. He has extensive experience in relation to patent disputes in the pharmaceutical, veterinary and agricultural areas, including patent infringement/revocation proceedings and extension of term disputes. Paul has worked on numerous successful pharmaceutical product launches for international and local innovator and generic pharmaceutical companies in Australia and New Zealand.
He has been involved in significant recent pharmaceutical patent litigation in Australia in respect of drugs including: Parecoxib, Darunavir, Bortezimib, Aripiprazole, Leflunomide, Perindopril, Paroxetine, Plendronate, Carvedilol, Enalapril, Rosuvastatin, Paracetamol, Gliclazide, Pregabalin. Paul has acted in respect of over 100 oppositions and re-examinations before the Australian Patent Office (IP Australia).
Technical expertise:
- Patent disputes
- Strategic IP advice
- Patent oppositions, re-examinations
- Litigation Support
Areas of expertise:
- Organic, Inorganic and Biological Chemistry
- Pharmaceutical Chemistry
- Medical treatments, diagnostics and medical devices
